Enacting the defense of drug delivery act to prohibit manufacturer interference relating to 340B drug distribution.

SB 284, the "Defense of Drug Delivery Act," prohibits drug manufacturers from restricting how 340B drugs are distributed to covered healthcare entities (like hospitals and clinics participating in the federal 340B drug pricing program). It specifically bans manufacturers from denying, limiting, or discriminating against the delivery of 340B drugs to these entities unless prohibited by federal law or state law. The bill also prevents manufacturers from requiring covered entities to share health information, claims data, or purchasing details unless voluntarily provided or legally mandated. This directly affects covered entities by ensuring they can access discounted drugs without manufacturer-imposed barriers.